Description of Baseline Characteristics of Pediatric Allergic Asthma Patients Including those Initiated on Omalizumab

BACKGROUND: Indication of omalizumab in the United States was recently extended to include pediatric (6–11 years) uncontrolled moderate-to-severe allergic asthma patients. OBJECTIVE: The purpose of this study was to describe baseline characteristics of this population from a real-world dataset. METH...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Allergy Rhinol (Providence)
Autori principali: Kavati, Abhishek, Pilon, Dominic, Ortiz, Benjamin, Paknis, Brandee, Vegesna, Ashok, Schiffman, Bradd, Zhdanava, Maryia, Lefebvre, Patrick, Stone, Brian
Natura: Artigo
Lingua:Inglês
Pubblicazione: SAGE Publications 2018
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6028162/
https://ncbi.nlm.nih.gov/pubmed/29977648
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2152656718763387
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi